In short: Peptide blends combine two or more compounds in a single vial so researchers can study interacting pathways together. Common examples include CJC-1295 with Ipamorelin (growth-hormone axis) and multi-peptide recovery blends. Blends are a convenience and design choice, not an efficacy claim.

What a blend actually is

A blend is a single lyophilised preparation containing more than one peptide at defined amounts. Researchers use blends when the compounds are studied together, reducing preparation steps and variability between separate vials.

Examples in the Research Series

CJC-1295 (No DAC) + Ipamorelin pairs two compounds studied in the growth-hormone-releasing pathway, while the GLOW blend (BPC-157 + GHK-Cu + TB-500) combines peptides examined in tissue-research contexts. Each is batch-documented like every MyoLabs compound.

Frequently Asked Questions

Why are peptides sold as blends?

To let researchers study interacting compounds together in one preparation, reducing handling steps and cross-vial variability.

Is a blend stronger than single peptides?

No — a blend is a formulation choice for research convenience, not a claim of greater effect. These are research compounds only.

How are blends reconstituted?

Like single peptides, blends are reconstituted with bacteriostatic water and handled gently to preserve integrity.

Research Use Only. MyoLabs products are supplied strictly for laboratory and research use. They are not medicines and are not for human or animal consumption, diagnosis, treatment, or prevention of any condition. Always comply with the laws of your jurisdiction.